Sutro Biopharma Inc (NASDAQ: STRO) is 0.54% higher on its value in year-to-date trading and has touched a low of $1.67 and a high of $6.13 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The STRO stock was last observed hovering at around $1.83 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $1.85, the stock is -2.43% and -28.07% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.87 million and changing 1.09% at the moment leaves the stock -47.81% off its SMA200. STRO registered -52.20% loss for a year compared to 6-month loss of -54.43%. The firm has a 50-day simple moving average (SMA 50) of $2.6058 and a 200-day simple moving average (SMA200) of $3.5622.
The stock witnessed a -12.74% gain in the last 1 month and extending the period to 3 months gives it a -51.70%, and is -5.13% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.83% over the week and 7.89% over the month.
Sutro Biopharma Inc (STRO) has around 302 employees, a market worth around $152.55M and $160.96M in sales. Profit margin for the company is -77.01%. Distance from 52-week low is 10.78% and -69.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.20%).
with sales reaching $12.18M over the same period.The EPS is expected to shrink by -62.82% this year, but quarterly earnings will post -61.49% year-over-year. Quarterly sales are estimated to shrink -89.29% in year-over-year returns.
177.0 institutions hold shares in Sutro Biopharma Inc (STRO), with institutional investors hold 77.79% of the company’s shares. The shares outstanding are 82.40M, and float is at 76.30M with Short Float at 4.13%. Institutions hold 77.06% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 6.91 million shares valued at $20.25 million. The investor’s holdings represent 11.2447 of the STRO Shares outstanding. As of 2024-06-30, the second largest holder is SUVRETTA CAPITAL MANAGEMENT, LLC with 7.71 million shares valued at $22.59 million to account for 9.4906 of the shares outstanding. The other top investors are POINT72 ASSET MANAGEMENT, L.P. which holds 4.45 million shares representing 5.4757 and valued at over $13.03 million, while MILLENNIUM MANAGEMENT LLC holds 5.3702 of the shares totaling 4.36 million with a market value of $12.78 million.
Sutro Biopharma Inc (STRO) Insider Activity
The most recent transaction is an insider sale by Vasquez Nicki, the company’s CHIEF PORT. STRAT & ALNCE OFCR. SEC filings show that Vasquez Nicki sold 12,185 shares of the company’s common stock on Jan 29 ’24 at a price of $5.00 per share for a total of $60925.0. Following the sale, the insider now owns 12803.0 shares.
